This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignees: Whitehead Institute for Biomedical Research, Memorial Sloan Kettering Cancer Center, The Rockefeller University. Active years: 2016-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2016-2023
Title: Bryce Woodbury Carey: Innovator in Cell Reprogramming
Introduction
Bryce Woodbury Carey is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cell reprogramming, holding a total of three patents. His work focuses on advancing our understanding of cellular differentiation and proliferation.
Latest Patents
One of his latest patents is titled "Nucleic acid constructs encoding reprogramming factors linked by self-cleaving peptides." This invention relates to a method of reprogramming somatic cells to a less differentiated state, such as a pluripotent or multipotent state. The patent also covers reprogrammed somatic cells produced by these methods, chimeric animals comprising these cells, and methods for identifying agents useful for reprogramming. Another significant patent is "Modulating cell proliferation and pluripotency," which discloses compositions, systems, and methods for modulating the proliferation, differentiation, and pluripotency of cells.
Career Highlights
Bryce has worked at prestigious institutions, including the Whitehead Institute for Biomedical Research and Memorial Sloan Kettering Cancer Center. His work at these organizations has contributed to groundbreaking research in the field of biomedical science.
Collaborations
Throughout his career, Bryce has collaborated with esteemed colleagues, including Rudolf Jaenisch and Yaqub Hanna. These collaborations have further enriched his research and innovations in cell reprogramming.
Conclusion
Bryce Woodbury Carey is a pioneering inventor whose work in cell reprogramming has the potential to transform biomedical research and therapeutic applications. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile